FDA 483 - Bellaire Aesthetics Inc. - July 22, 2019

An FDA inspection of Bellaire Aesthetics Inc. in Middle Island, NY, revealed significant deficiencies in their quality system. The firm failed to establish written procedures for controlling storage areas, managing product complaints, and developing Medical Device Report (MDR) processes. These findings indicate a lack of fundamental controls for a medical device manufacturer.